Table 1 of Pauly, Mol Vis 2011; 17:745-755.
Eye drops |
Active compound content |
BAC content |
---|---|---|
Ketotifen fumarate (Zaditen®; Novartis Pharma SAS,Rueil-Malmaison, France) | 0.025% | 0.01% |
Olopatadine chlorhydrate (Opatanol®; Patanol®; Alcon, Ft. Worth, TX) | 0.1% | 0.01% |
Epinastine chlorhydrate (Purivist®; Allergan, Irvin, CA) | 0.05% | 0.01% |
Levocabastine chlorhydrate (Levophta®; Chauvin Bausch & Lomb, Montpellier, France) | 0.05% | 0.015% |
Preservative-free ketotifen fumarate (Zalerg®; Thea, Clermont-Ferrand, France) | 0.025% | - |
Preservative-free NAAGA (NAABAK®; Thea, Clermont-Ferrand, France) | 4.9% | - |
Preservative-free sodium cromoglycate (Cromabak®; Thea, Clermont-Ferrand, France) | 2% | - |